Corpay (CPAY)
NYSEFinancialsSoftware - InfrastructureSnapshot 2026-11-05
NYSEFinancialsSoftware - InfrastructureSnapshot 2026-11-05
Research Workspace
Put CPAY beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 20% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 45% growth a year, above the roughly 13% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskCorpay's double-digit organic growth engine has to keep compounding to justify the price. Revenue grew 18% year over year in the latest quarter. The company beat earnings estimates by 11.9% in Q3 2026. It trades at 17x earnings versus a 12x peer median. The market is pricing in more growth than we forecast. A guidance cut after a recent raise would be a severe credibility hit. Peer multiples imply a price about 45% below where it trades. Our read remains intact.
Trailing returns as of 2026-11-05. CPAY is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 16 analysts currently covering CPAY (as of Nov 2026).
Based on 8 Wall Street analysts offering 12-month price targets for CPAY in the last 4 months.
Continue this research
Compare CPAY with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CPAY Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Transaction & Payment Processing Services — fair value, gap to price, and forward P/E.
Compare the value case
Put CPAY next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Achieve double-digit organic revenue growth
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Current $447.00
The last 12 months of price, then the range of analyst 12-month targets from today’s $447.00.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Confirms double-digit organic growth target for 2027.

Advances: Drive meaningful adjusted EPS growth in 2026
Earnings beat supports adjusted EPS growth objective.

Settlement may impact financial resources and reputation.

Simplifying business may hinder revenue growth objectives.

Cautious guidance may hinder revenue growth.